Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.

MLA

Mu, Linjing, et al. “Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.” Pharmaceuticals (Basel, Switzerland), vol. 7, no. 3, Mar. 2014, pp. 339–52. EBSCOhost, https://doi.org/10.3390/ph7030339.

APA

Mu, L., Slavik, R., Müller, A., Popaj, K., Cermak, S., Weber, M., Schibli, R., Krämer, S. D., & Ametamey, S. M. (2014). Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor. Pharmaceuticals (Basel, Switzerland), 7(3), 339–352. https://doi.org/10.3390/ph7030339

Chicago

Mu, Linjing, Roger Slavik, Adrienne Müller, Kasim Popaj, Stjepko Cermak, Markus Weber, Roger Schibli, Stefanie D Krämer, and Simon M Ametamey. 2014. “Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.” Pharmaceuticals (Basel, Switzerland) 7 (3): 339–52. doi:10.3390/ph7030339.